Schedule 13G ownership disclosure
AN2 Therapeutics, Inc.
Common Stock and Warrants · CUSIP: 037326105
Event date: 2025-09-30
- Filing-level shares
- 1,428,323.00
- Percent of class
- 5.2%
- Almitas Capital LLC
Shares: 1,428,323.00 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001596468-25-000022
- Form type
- SCHEDULE 13G
- Filer
- AN2 Therapeutics, Inc.
- CIK
- CIK 1880438
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership